Markets:

Overview

News

Currencies

International

Treasuries

DexCom, Inc. - Common Stock (NQ:DXCM)

67.32 +0.98 (+1.48%)

Streaming Delayed Price Updated: 4:00 PM EDT, Mar 17, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about DexCom, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

47 48 Next >

Fortrea, Alignment Healthcare, PacBio, DexCom, and Humana Stocks Trade Up, What You Need To Know

March 16, 2026

What Happened? A number of stocks jumped in the afternoon session after easing crude oil prices helped lift investor sentiment and reduce inflation worries. ...

Via StockStory

Topics Economy Stocks

This Biotech Stock Up Nearly 100% in a Year Has Drawn a New $20 Million Share Investment ↗

March 15, 2026

EyePoint develops sustained-release treatments for retinal diseases, leveraging proprietary technology and strategic industry partnerships.

Via The Motley Fool

This Fund Built a $26 Million Stake in a Medical Tech Stock That's Soaring After a $9.9 Billion Deal Announcement ↗

March 15, 2026

This medical technology firm delivers advanced noninvasive monitoring and automation solutions to healthcare providers worldwide.

Via The Motley Fool

Topics Regulatory Compliance

DexCom Inc (NASDAQ:DXCM): A Prime Example of Growth at a Reasonable Price ↗

March 10, 2026

Via Chartmill

Dexcom Inc (NASDAQ:DXCM) Beats Q4 Profit Estimates Despite Revenue Shortfall ↗

February 12, 2026

Via Chartmill

This Internet Infrastructure Stock Plunged 72% in a Year, so Why Did an Investor Buy Up $12 Million? ↗

March 15, 2026

Cogent Communications delivers high-speed internet and data center services to commercial clients across multiple continents.

Via The Motley Fool

Topics Regulatory Compliance

Sotera Health Shares Rise 18% in a Year. Here's What a $37 Million Stake Trim Signals ↗

March 15, 2026

Sotera Health delivers sterilization and lab testing services to regulated industries worldwide, supporting critical supply chains.

Via The Motley Fool

Topics Regulatory Compliance

Dexcom Showcases Breakthrough Outcomes for People With Type 2 Diabetes and Product Roadmap at ATTD 2026

March 11, 2026

From DexCom, Inc.

Via Business Wire

2 Growth Stocks to Hold for the Next Decade ↗

March 10, 2026

They are down, but they are not out.

Via The Motley Fool

Topics World Trade

Bio-Techne, Bruker, DexCom, STERIS, and Teleflex Shares Plummet, What You Need To Know

March 06, 2026

What Happened? A number of stocks fell in the afternoon session after the February jobs report revealed an unexpected contraction in employment, with the hea...

Via StockStory

Topics Economy

Which S&P500 stocks are gapping on Wednesday? ↗

March 04, 2026

Via Chartmill

1 Nasdaq 100 Stock with Impressive Fundamentals and 2 We Avoid

March 03, 2026

While the Nasdaq 100 (^NDX) is filled with cutting-edge technology and consumer companies, not all are on solid footing. Some are dealing with declining demand, high costs, or regulatory pressures that...

Via StockStory

Dexcom Appoints Rick Osterloh to Board of Directors

February 26, 2026

From DexCom, Inc.

Via Business Wire

Got $10,000? I Think DexCom Stock Could Be a Quiet Winner of the GLP‑1 Wars ↗

February 25, 2026

It's another reason to invest in this exciting medical device stock.

Via The Motley Fool

Dexcom Announces Upcoming Conference Presentation

February 25, 2026

From DexCom, Inc.

Via Business Wire

The Great Unlocking: Medtronic’s Strategic Pivot and the MiniMed Spin-Off

February 24, 2026

Date: February 24, 2026 By: Financial Research Analyst Introduction For years, Medtronic plc (NYSE: MDT) was viewed by Wall Street as a reliable but sluggish giant—a "Dividend Aristocrat" that offered...

Via Finterra

Topics Artificial Intelligence Economy Initial Public Offering

The 5 Most Interesting Analyst Questions From DexCom’s Q4 Earnings Call

February 19, 2026

DexCom’s fourth quarter results reflected ongoing momentum in both product innovation and international expansion. Management attributed the quarter’s performance to the broad rollout of the G7 15-day...

Via StockStory

Topics Earnings

Insulet (PODD) Shakes the Market with Q4 Earnings Beat as Omnipod 5 Dominance Continues

February 18, 2026

Insulet Corporation (NASDAQ:PODD) delivered a commanding performance in its fourth-quarter earnings report released today, February 18, 2026. The medical device leader announced an adjusted earnings...

Via MarketMinute

Topics Earnings

Top S&P500 movers in Friday's session ↗

February 13, 2026

Via Chartmill

Friday's session: top gainers and losers in the S&P500 index ↗

February 13, 2026

Via Chartmill

Why Is DexCom (DXCM) Stock Rocketing Higher Today

February 13, 2026

Shares of medical device company DexCom (NASDAQ:DXCM) jumped 7.3% in the morning session after it reported better-than-expected fourth-quarter 2025 financial results, beating analyst estimates for both...

Via StockStory

Topics Artificial Intelligence Supply Chain

Soleus Adds a Significant Number of Celcuity Shares ↗

February 13, 2026

This clinical-stage biotech develops targeted cancer therapies and diagnostics using proprietary technology for personalized treatment.

Via The Motley Fool

DXCM Q4 Deep Dive: New Product Launches and International Strategy Drive Outlook

February 13, 2026

Medical device company DexCom (NASDAQ:DXCM) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 13.1% year on year to $1.26 billion. The company expects the full year’s...

Via StockStory

DexCom (DXCM) Q4 2025 Earnings Call Transcript ↗

February 12, 2026

DexCom (DXCM) Q4 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings Economy

DexCom (NASDAQ:DXCM) Exceeds Q4 CY2025 Expectations

February 12, 2026

Medical device company DexCom (NASDAQ:DXCM) announced better-than-expected revenue in Q4 CY2025, with sales up 13.1% year on year to $1.26 billion. The company expects the full year’s revenue to be...

Via StockStory

Dexcom Reports Fourth Quarter and Fiscal Year 2025 Financial Results

February 12, 2026

From DexCom, Inc.

Via Business Wire

Earnings To Watch: DexCom (DXCM) Reports Q4 Results Tomorrow

February 10, 2026

Medical device company DexCom (NASDAQ:DXCM) will be reporting earnings this Thursday after market hours. Here’s what you need to know.

Via StockStory

Topics Artificial Intelligence

1 High-Flying Stock with Impressive Fundamentals and 2 We Ignore

February 08, 2026

"You get what you pay for" often applies to expensive stocks with best-in-class business models and execution. While their quality can sometimes justify the premium, they typically experience elevated...

Via StockStory

1 Cash-Producing Stock Worth Your Attention and 2 Facing Headwinds

February 05, 2026

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.

Via StockStory

Stelo Adds Enhanced Smart Meal Logging Features as Dexcom Continues to Transform Personal Glucose Management

February 04, 2026

From Dexcom, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9

...

47 48 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.